Tanaka H, Shigenobu K (2002). “Efonidipine hydrochloride: a dual blocker of L- and T-type Ca2+ channels”. Cardiovasc. Drug Rev.20 (1): 81-92. PMID12070536.
Toyoda K, Kitahara M, Yamashita T, et al (May 1994). “[Effect of efonidipine hydrochloride (NZ-105), a new dihydropyridine calcium antagonist, on the experimental atherosclerosis in cholesterol-fed rabbits]” (Japanese). Nippon Yakurigaku Zasshi103 (5): 231–9. PMID8188119.
Shudo C, Masuda Y, Sugita H, Tanaka S, Tomita K (November 1994). “Effects of efonidipine hydrochloride (NZ-105), a new calcium antagonist, against acute renal failure in rats”. Gen. Pharmacol.25 (7): 1451–8. PMID7896060.